Nav: Home

A deep look at nasal polyps offers insights into allergic diseases

August 22, 2018

Nasal polyps - soft, grape-like outgrowths that can appear in the nasal passages and sinuses - can be chronic and relentless. Although noncancerous, these outgrowths can grow large enough to block the nose and sinuses, leading to discomfort, breathing problems and infections. Nasal polyps can be surgically removed, but may grow back, sometimes in a matter of days. Although most patients are happy to be rid of their polyps, for researchers, that tissue is precious: It may hold critical clues about intense, allergic inflammation. Investigators from Brigham and Women's Hospital, along with collaborators from the Broad Institute and MIT, have used some of the most advanced sequencing technology to peer into nasal polyps, gleaning new insights not only into this condition but also the severe form of inflammation that may lead to other disorders, such as asthma, allergic rhinitis and allergic eczema. The team's findings are published Aug. 22 online in Nature.

"For our patients, one of the most frustrating things about chronic, allergic conditions is that we have no cure. Surgery can relieve discomfort for those with nasal polyps, but in many cases the effect is only temporary," said co-corresponding author Nora Barrett, MD, a physician in the Division of Rheumatology, Immunology, and Allergy at BWH. "My group's goal is to understand why the inflammatory process persists once it begins and to uncover the cause of these conditions."

Barrett and colleagues obtained samples from 12 patients with nasal polyps or other sinus conditions, for a total collection of 18,036 cells. They compared these to nasal scrapings from healthy individuals. Barrett and her team member Dan Dwyer, PhD, partnered with Alex K. Shalek, PhD, of the Broad Institute, Ragon and MIT, and his postdoctoral fellow Jose Ordovas-Montanes, PhD, to use massively-parallel, single-cell RNA sequencing - a technique that allows investigators to determine genes turned on in each cell recovered. Rather than focusing on just one kind of suspected cell, they used this approach to look at every cell type found in harvested samples.

What they found surprised them. One of the most striking findings the researchers reported was that epithelial progenitor cells, stem-like cells which give rise to the cells that line the airways, had been completely remodeled in the polyp samples. And they had been permanently altered. In fact, even when removed from the tissue and grown in the lab, the resulting cells showed marked genetic differences.

"We found that stem-like epithelial cells expressed an aberrant program," said Barrett. "To a dramatic extent, inflammation had changed the basic tissue architecture at the genetic level."

The Nature publication offers a global, cellular map of inflamed tissue for what is known as type 2 inflammation - a severe form of inflammation that involves immune cells that have gone rogue, triggering a cascade of immune action. The map points to many pathways that have been altered, and Barrett and colleagues are working through these to identify which ones may be driving inflammation and which ones may be resulting from the inflammatory process. The research team also tested a monoclonal antibody that helped restore normal genetic activity - suggesting that it may be possible to develop therapies in the future to restore a normal balance to cells that have been altered through inflammation.

The team also hopes to use the new information to develop a genetic signature that would allow clinicians to take a swab of nasal mucosa to test for lung conditions. Using the new map to chart the key characteristics of type 2 inflammation could yield the tools needed to predict disease states and, potentially, direct targeted therapy.
Funding for this work was provided by the Jeff and Penny Vinik Center for Allergic Disease Research, the Searle Scholars Program, the Beckman Young Investigator Program, the Pew Stewart Scholars, a Sloan Fellowship in Chemistry, NIH grants (1DP2OD020839, 2U19AI089992, 1U54CA217377, P01AI039671, 5U24AI118672, 2RM1HG006193, 1R33CA202820, 2R01HL095791, 1R01AI138546, 1R01HL126554, 1R01DA046277, 2R01HL095791), Bill and Melinda Gates Foundation grants (OPP1139972 and BMGF OPP1116944)? NIH R01HL120952, Steven and Judy Kaye Young Innovators Award, NIH R01HL128241, NIH U19AI095219, T32AI007306, NIH AADCRC Opportunity Fund Award U19AI070535, NIH K23AI118804, NIH 2R01GM08187109, the Koch Institute Support (core) Grant P30CA14051 from the NCI, and Ragon Institute NIH-funded Centers for AIDS Research (P30 AI060354, Harvard University Center for AIDS Research), supported by NIH cofounding and participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC, and the HHMI Damon Runyon Cancer Research Foundation Fellowship (DRG227416).

Brigham and Women's Hospital (BWH) is a 793-bed nonprofit teaching affiliate of Harvard Medical School and a founding member of Partners HealthCare. BWH has more than 4.2 million annual patient visits and nearly 46,000 inpatient stays, is the largest birthing center in Massachusetts and employs nearly 16,000 people. The Brigham's medical preeminence dates back to 1832, and today that rich history in clinical care is coupled with its national leadership in patient care, quality improvement and patient safety initiatives, and its dedication to research, innovation, community engagement and educating and training the next generation of health care professionals. Through investigation and discovery conducted at its Brigham Research Institute (BRI), BWH is an international leader in basic, clinical and translational research on human diseases, more than 3,000 researchers, including physician-investigators and renowned biomedical scientists and faculty supported by nearly $666 million in funding. For the last 25 years, BWH ranked second in research funding from the National Institutes of Health (NIH) among independent hospitals. BWH is also home to major landmark epidemiologic population studies, including the Nurses' and Physicians' Health Studies and the Women's Health Initiative as well as the TIMI Study Group, one of the premier cardiovascular clinical trials groups. For more information, resources and to follow us on social media, please visit BWH's online newsroom.

Brigham and Women's Hospital

Related Inflammation Articles:

TWEAKing inflammation
Superficially, psoriasis and atopic dermatitis may appear similar but their commonalities are only skin deep.
More than a 'gut feeling' on cause of age-associated inflammation
Bowdish and her colleagues raised mice in germ-free conditions and compared them to their conventionally raised counterparts.
Inflammation: It takes two to tango
Signal molecules called chemokines often work in tandem to recruit specific sets of immune cells to sites of tissue damage.
Inflammation awakens sleepers
The inflammatory response that is supposed to ward off pathogens that cause intestinal disease makes this even worse.
Inflammation in regeneration: A friend or foe?
Scientists at Tokyo Institute of Technology have discovered a novel mechanism linking inflammation and organ regeneration in fish, which can be conserved among vertebrates.
New RNAi treatment targets eye inflammation
Scientists have developed a new RNA interference (RNAi) therapeutic agent that safely blocked ocular inflammation in mice, potentially making it a new treatment for human uveitis and diabetic retinopathy.
Every meal triggers inflammation
When we eat, we do not just take in nutrients -- we also consume a significant quantity of bacteria.
Inflammation halts fat-burning
Scientists at the University of Bonn have shown in mice that excess pounds can simply be melted away by converting unwanted white fat cells into energy-consuming brown slimming cells.
New tool uses UV light to control inflammation
Cornell researchers have developed a chemical tool to control inflammation that is activated by ultraviolet (UV) light.
Myocardial inflammation elevated in RA patients
Two new studies measure the prevalence of myocardial inflammation in RA patients without known cardiovascular disease, assess how it is associated with high disease activity and show how disease-modifying therapy may decrease this type of inflammation, according to new research findings presented this week at the 2016 ACR/ARHP Annual Meeting in Washington.

Related Inflammation Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Jumpstarting Creativity
Our greatest breakthroughs and triumphs have one thing in common: creativity. But how do you ignite it? And how do you rekindle it? This hour, TED speakers explore ideas on jumpstarting creativity. Guests include economist Tim Harford, producer Helen Marriage, artificial intelligence researcher Steve Engels, and behavioral scientist Marily Oppezzo.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".